Ignite Creation Date:
2024-05-05 @ 5:00 PM
Last Modification Date:
2024-10-26 @ 9:26 AM
Study NCT ID:
NCT00363545
Status:
COMPLETED
Last Update Posted:
2018-06-08
First Post:
2006-08-11
Brief Title:
To Assess Immunogenicity Reactogenicity Safety of 2 Formulations of GSKs HRV Vaccine as 2-dose Vaccination Infants
Sponsor:
GlaxoSmithKline
Organization:
GlaxoSmithKline
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-09-01
Start Date Type:
ACTUAL
Primary Completion Date:
2007-04-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2007-04-12
Completion Date Type:
ACTUAL
First Submit Date:
2006-08-11
First Submit QC Date:
August 11 2006
Study First Post Date:
2006-08-15
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2017-02-23
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-05-09
Last Update Post Date:
2018-06-08
Last Update Post Date Type:
ACTUAL